No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program
L. Unkila-kallio et al., No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program, AM J REPROD, 43(1), 2000, pp. 25-30
PROBLEM: To compare changes in serum Vascular endothelial growth factor (VE
GF) levers during normal and in vitro fertilization (IVF) cycles.
METHOD OF STUDY: Ten healthy women with ovulatory cycles and 37 infertile w
omen participating in an IVF program were followed by frequent serum sample
s and with VEGF measurements throughout their cycles.
RESULTS: Serum VEGF remained unchanged during the normal menstrual cycle, w
hereas the IVF program participants showed elevations in serum VEGF in the
luteal phase of the cycle. When data from controls and patients were pooled
, redundant midluteal VEGF level correlated with progesterone and with peak
follicular phase estrogen level. The midluteal VEGF level in the IVF cycle
s was associated with body mass index (P < 0.01) and progesterone level (P
< 0.05) by multiple regression. The 14 women conceiving tended to have high
er VEGF levels than those failing to become pregnant.
CONCLUSIONS: The IVF program was associated with increased synthesis of VEG
F either in the ovaries, endometrium, or at other sites and this may be of
significance for the outcome of IVF.